Malignant Hepatobiliary Neoplasm Clinical Trial
Official title:
Social Determinants of Health in Hepatobiliary Cancer Patients
This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.
PRIMARY OBJECTIVE: I. To characterize the social determinants of health - and specifically travel-limiting access to cancer care but also other issues, such as trouble in finding childcare, joblessness, and limited education - among Southeast Asian Americans with hepatobiliary cancers, exposure risk including aflatoxin and viral hepatitis among other exposures. OUTLINE: This is an observational study. Patients complete a questionnaire, undergo blood sample collection and have their medical records reviewed on study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02916199 -
Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
|
N/A | |
| Completed |
NCT05068739 -
Needle Knife Fistulotomy Versus Partial Ampullary Endoscopic Mucosal Resection for Difficult Biliary Cannulation
|
N/A | |
| Not yet recruiting |
NCT03195075 -
Endoscopic Ultrasonography Guided Biliary Drainage
|
N/A | |
| Recruiting |
NCT03857958 -
Metal Versus Plastic Stent in Malignant Hilar Biliary Obstruction
|
N/A | |
| Completed |
NCT03112668 -
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
|
N/A | |
| Completed |
NCT02265341 -
Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions
|
Phase 2 | |
| Recruiting |
NCT04704661 -
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
|
Phase 1 | |
| Recruiting |
NCT05334069 -
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
|